Pages that link to "Q36367821"
Jump to navigation
Jump to search
The following pages link to Cytotoxic T lymphocytes to an unmutated tumor rejection antigen P1A: normal development but restrained effector function in vivo. (Q36367821):
Displaying 20 items.
- The heat-stable antigen determines pathogenicity of self-reactive T cells in experimental autoimmune encephalomyelitis (Q28591104) (← links)
- Modulation of NKT cell development by B7-CD28 interaction: an expanding horizon for costimulation (Q30845162) (← links)
- Transgenic expression of P1A induced thymic tumor: a role for onco-fetal antigens in tumorigenesis (Q33728430) (← links)
- Tumor expression of CD200 inhibits IL-10 production by tumor-associated myeloid cells and prevents tumor immune evasion of CTL therapy (Q34412294) (← links)
- Immune competence of cancer-reactive T cells generated de novo in adult tumor-bearing mice (Q35615758) (← links)
- IL-10 contributes to the suppressive function of tumour-associated myeloid cells and enhances myeloid cell accumulation in tumours. (Q35757368) (← links)
- IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4(+) T cells and promoting CTL persistence in a murine model of plasmacytoma (Q35799158) (← links)
- Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies. (Q35848463) (← links)
- CD24 on thymic APCs regulates negative selection of myelin antigen-specific T lymphocytes (Q35983806) (← links)
- Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma. (Q36004284) (← links)
- Perinatal blockade of b7-1 and b7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells (Q36370130) (← links)
- B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. (Q36370918) (← links)
- Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. (Q36371632) (← links)
- B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo (Q36376380) (← links)
- Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells (Q36404025) (← links)
- Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40. (Q36440066) (← links)
- De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model. (Q36459332) (← links)
- Combined adjuvants of poly(I:C) plus LAG-3-Ig improve antitumor effects of tumor-specific T cells, preventing their exhaustion (Q36801213) (← links)
- Neoantigen: A Long March toward Cancer Immunotherapy (Q36963359) (← links)
- Expression of anti-HVEM single-chain antibody on tumor cells induces tumor-specific immunity with long-term memory. (Q37102329) (← links)